199 related articles for article (PubMed ID: 32903061)
1. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
2. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1α are elevated in pediatric migraine attacks.
Kilinc YB; Kilinc E; Danis A; Hanci F; Turay S; Ozge A; Bolay H
Headache; 2023 Sep; 63(8):1076-1086. PubMed ID: 37596867
[TBL] [Abstract][Full Text] [Related]
4. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
5. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
6. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
7. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
[TBL] [Abstract][Full Text] [Related]
8. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally.
Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R
Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297
[TBL] [Abstract][Full Text] [Related]
10. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
11. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
12. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
Lukacs M; Tajti J; Fulop F; Toldi J; Edvinsson L; Vecsei L
Curr Med Chem; 2017; 24(33):3649-3665. PubMed ID: 28707585
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides.
Absood A; Chen D; Håkanson R
Regul Pept; 1992 Aug; 40(3):311-22. PubMed ID: 1332141
[TBL] [Abstract][Full Text] [Related]
14. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
16. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
18. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.
Tuka B; Nyári A; Cseh EK; Körtési T; Veréb D; Tömösi F; Kecskeméti G; Janáky T; Tajti J; Vécsei L
J Headache Pain; 2021 Jun; 22(1):60. PubMed ID: 34171996
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide localization in the "migraine generator" region of the human brainstem.
Tajti J; Uddman R; Edvinsson L
Cephalalgia; 2001 Mar; 21(2):96-101. PubMed ID: 11422090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]